). Approximately 2,700 independent Tn4400'-derived mutants of P. gingivalis were examined for increased sensitivity to PMB killing at a relatively low dose (50 µg⋅mL -1 ). A single PMB-sensitive mutant was obtained in this phenotypic screen. We determined that the Tn4400' transposon was integrated into the gene encoding the lipid A 4'-phosphatase, PGN_0524, demonstrating that this insertion event was responsible for its increased susceptibility of this clone to PMB-dependent killing. The resulting mutant strain, designated 0524-Tn4400', was highly sensitive to PMB killing relative to wild-type P.
Introduction
Porphyromonas gingivalis (P. gingivalis), a prominent Gram-negative oral bacterium in the human oral cavity, is believed to play a fundamental role in the development and progression of periodontal disease in the host based upon a substantial amount of clinical evidence (Socransky et al., 1994; Socransky et al., 1998) . Multiple potential virulence factors have been identified in P. gingivalis that may contribute to its pathogenicity. These factors include fimbriae, which are utilized for host cell invasion and subversion of Toll-like receptor responses (Njoroge et al., 1997; Hajishengallis et al., 2008) and cysteine proteases which destroy both host extra-cellular matrix components and host innate immune mediators (Takii et al., 2005) . Notably, the lipopolysaccharide (LPS) of P. gingivalis exhibits an unusually low endotoxic potency in its ability to stimulate host innate immune defenses relative to the potencies that are associated with classic responses elicited by LPS derived from Gram-negative bacteria such as Escherichia coli (E. coli) (Mansheim et al., 1978; Nair et al., 1983) . A number of independent studies have implicated this unusual bacterial LPS as potentially playing a role in the ability of P. gingivalis to either evade or subvert host innate immune responses. For example, early studies conducted in our laboratory indicated that not only did P. gingivalis LPS fail to elicit strong host innate immune responses such as E-selectin induction, but it also antagonized the immunostimulatory activity of agonsitic LPS (Darveau et al., 1995) . Subsequent investigations demonstrated that the antagonistic capacity displayed by P. gingivalis LPS isolates was due to competitive inhibition of agonistic LPS interaction at the host Toll-like receptor 4 (TLR4) complex (Hajishengallis et al., 2002; Coats et al., 2003; Coats et al., 2005; Coats et al., 2007) , which forms a major host sensing mechanism to Gram-negative bacterial infections (Beutler, 2000; Munford et al., 2006) .
Gram-negative bacteria typically produce a mature lipid A bearing di-phosphorylated lipid A structures capable of activating TLR 4 (Poltorak et al., 1998; Raetz et al., 2007) . Structural modifications of lipid A including dephosphorylation and deacylation (Peterson et al., 1987; Kovach et al., 1990; Rietschel et al., 1994) can markedly reduce the ability of the LPS to stimulate pro-inflammatory host TLR4 responses (Kawasaki et al., 2004; MataHaro et al., 2007) , produce lipid A antagonists (Kovach et al., 1990) , or enhance the ability of the bacterium to resist cationic antimicrobial peptides such as polymyxin B (PMB) presumably through the loss of negative charge from either the lipid A 1-or 4'-phosphate (Tran et al., 2006; Wang et al., 2007) . Following more than a decade of intensive inquiry aimed at understanding the molecular basis for the low reactivity associated with P. gingivalis LPS, it is now apparent that the distinctive low endotoxic potential associated with the LPS of this bacterium is due to post-synthetic modifications of the lipid A component of its mature LPS including lipid A 1-and 4'-dephosphorylation and lipid A 3'-O-deacylation (Coats et al., 2009) . It has previously been shown that P. gingivalis synthesizes LPS containing a diphosphorylated, penta-acylated lipid A structure that is capable of promoting a relatively robust innate immune response (Kumada et al., 1995; Kumada et al., 2008) . The immunostimulatory potential of the di-phosphorylated, penta-acylated lipid A is greatly reduced by the activity of endogenous lipid A 1-and 4'-phosphatases combined with an unidentified 3'-O-deacylase activity to generate a mono-phosphorylated, tetraacylated lipid A TLR4 antagonist and a novel non-phosphorylated, tetra-acylated lipid A that is highly inert in its ability to stimulate TLR4 responses in human endothelial cells or innate immune responses in monocytes (Rangarajan et al., 2008; Coats et al., 2009) . The lipid A 1-phosphatase activity in P. gingivalis ATCC 33277, encoded by PGN_1713 (Naito et al., 2008; Coats et al., 2009 ) (previously denoted PG1773 based upon the W83 genomic sequence), is involved in the hemin-dependent production of the lipid A antagonist which is capable of inhibiting agonistic LPS isolates from both P. gingivalis and E. coli. The lipid A 4'-phosphatase activity, encoded by PGN_0524 (Naito et al., 2008; Coats et al., 2009 ) (previously denoted PG1587 based upon the W83 genomic sequence), appears to be required for subsequent 3'-O-deacylation of the penta-acylated lipid A precursor by an unidentified deacylase activity (Coats et al., 2009 ).
Experiments performed with P. gingivalis bearing a deletion of PGN_0524, 0524KO (previously denoted 1587KO), revealed that this lipid A 4'-phosphatase activity suppresses the ability of P. gingivalis LPS to activate TLR4 by promoting the formation of non-phosphorylated and mono-phosphorylated tetra-acylated lipid A from a pentaacylated lipid A precursor. Another prominent feature of the 0524KO strain is that it is highly sensitive to the killing action of the cationic antimicrobial peptide, PMB as compared to the isogenic wild-type strain (Coats et al., 2009) . This finding suggests that lipid A 4'-phosphatase modification of the lipid A structure reduces the ability of P. gingivalis to stimulate TLR4 and establishes its resistance to cationic antimicrobial peptides, which constitute an important aspect of host innate immunity (Bals, 2000) . However, it is presently unclear as to whether or not additional genetic elements are involved in establishing resistance to PMB in P. gingivalis.
In this study, we developed a genetic screen to further explore the genetic basis of PMB resistance by P. gingivalis. We employed a previously developed transposon-mediated mutagenesis system that utilizes Tn4400' to generate a library of random mutants in P. gingivalis ATCC 33277 (Chen et al., 2000; Tang et al., 2000) . The resulting mutants (approximately 2,700 independent clones) were subjected to a simple screen to identify PMB-sensitive mutants. The identification and characterization of a single PMB-sensitive clone that was obtained by this procedure is described in this report. . Cultures were grown in an anaerobic growth chamber (5% H 2 , 5% CO 2 , 90% N 2 ) and maintained at 37ºC on TYHK-agar plates. The 0524KO strain of P. gingivalis (previously designated 1587KO), was previously generated by homologous recombination replacement of the PGN_0524 coding region with an erythromycin resistance cassette (Coats et al., 2009) . In all experiments, the 0524KO strain was cultured in TYHK medium supplemented with 5 µg⋅mL -1 erythromycin.
Materials and methods

Bacterial
Tn4400'-based mutagenesis of P. gingivalis and PMB sensitivity screen
A conjugation method based upon a previously described procedure was used to generate random Tn4400'-mediated insertion mutations in the genome of P. gingivalis ATCC 33277 (Chen et al., 2000; Tang et al., 2000) . For a typical tri-parental mating, a HB101 strain of E. coli containing pRK231 (plasmid encoding mobilization element) and a DH10B strain of E. coli containing pYT-646B (plasmid encoding the Tn4400 transposon) were grown in Luria broth to an OD 600 ~ 0.8. P. gingivalis was grown in 200 mL TYHK medium to an OD 600 ~ 1.0, were pelleted and resuspended in 5 mL of TYHK medium. Subsequently, 1.5 mL of P. gingivalis culture was combined with 0.5 mL of HB101 (pRK231) and 0.5 mL of DH10B (pYT-646B). The mixture was pelleted, resuspended in 400 µL of TYHK, spotted on a 0.45 µmol⋅L -1 HA nitrocellulose filter (Millipore) that had been placed in the center of a TYHK-agar plate, and incubated aerobically at 37°C for 18-20 hours. After aerobic incubation, the bacterial mixture was re-suspended in 2 mL of TYHK medium and 100 µL aliquots of the suspension were plated on TYHK-agar plates containing 1 µg⋅mL -1 tetracycline (to select for the Tn4400' configuration of Tn4400) and 100 µg⋅mL -1 gentamycin (to counter-select E. coli). Following 8-10 days of incubation in an anaerobic chamber at 37°C, individual colonies were picked and inoculated into 100 µL TYHK medium containing 1 µg⋅mL -1 tetracycline and cultured for 2 days anaerobically at 37ºC. To conduct the PMB screen, approximately 2 µL of each culture was replica plated on TYHK plates containing either no PMB or 50 µg⋅mL -1 PMB and scored for +/-growth after two days.
Identification of the PGN_0524 gene coding sequence as the site of TN4400' integration in the chromosome of P. gingivalis A genomic DNA preparation was prepared from clone 8-1. Polymerase chain reactions (PCR) using clone 8-1 genomic DNA were performed using primers that are specific for the 5'-and 3'-flanking regions of PGN_0524 ( SJ163 and SC337 respectively) in combination with primers that are specific for the right hand side ('a') or left hand side ('c') of the Tn4400' insertion element (Chen et al., 2000) to determine the orientation of the Tn4400' transposon within the PGN_0524 locus ( Figure 1 ). Subsequent sequencing analyses of the resulting PCR fragments were performed using the primers that interact with the 5'-end (primer SJ149) or the 3'-end (primer SJ150) of the coding sequence to determine the site of transposon integration. The sequences of the primers used in this study are in the PGN_0524 locus was determined by PCR analyses using primers derived from the upstream (primer SJ163) and downstream (primer SC337) flanking regions of the PGN_0524 gene in combination with primers derived from the left (primer a) and right (primer c) ends of the insertion sequences of Tn4400' (grey shaded arrows) (Chen et al., 2000) . Sequencing of the PCR fragments derived from these PCR analyses using primers that interact with the 5'-end of the coding sequence (primer SJ149) and the 3'-end of the coding sequence (primer SJ150) revealed that Tn4400' was integrated at base-pair (bp) position 404 bp of the 717 bp PGN_0524 coding sequence (vertical arrow).
This integration event results in a disruption of the protein product at phenylalanine 133 (F133).
PMB sensitivity assay
Overnight cultures of wild-type P. gingivalis 33277 and the derivative isogenic mutant strains, 0524KO and 0524-Tn4400', were grown in THYK media containing hemin (1 µg⋅mL -1 ). Wild-type P.
gingivalis, 0524KO, and 0524-Tn4400' bacterial starter cultures were subsequently inoculated into 5 mL TYHK media cultures (initial OD 600 =0.1) containing various doses of PMB (0, 2.5, 5, 25, 50, 100, and 200 µg⋅mL -1 ) and grown in an anaerobic chamber at 37ºC for 24 hours. Final OD 600 was measured for each sample. For each strain, the percent growth was calculated by dividing the OD 600 of the cultures containing PMB by the OD 600 of the cultures without PMB to determine PMB susceptibility for the respective strains.
LPS and lipid A isolation
Bacteria were cultured for 48 hours in TYHK medium containing 1 µg⋅mL -1 hemin. LPS was isolated using a modified version of the Trireagent protocol for LPS isolation as previously described 
MALDI-TOF analysis
For MALDI-TOF MS analyses, lipid A samples were dissolved in 10 µL of a solution containing the matrix, 5-chloro-2-mercaptobenzothiazole (20 mg⋅mL -1 ), dissolved in a mixture of chloroform/methanol 1:1 (V/V). Subsequently, 0.5 µL of each sample was analyzed in both positive and negative ion modes on an AutoFlex Analyzer (Bruker Daltonics). Data were acquired with a 50 Hz repletion rate and up to 3,000 shots were accumulated for each spectrum. Instrument calibration and all other tuning parameters were optimized using HP Calmix (Sigma-Aldrich, St. Louis, USA). Data was acquired and processed using flexAnalysis software (Bruker Daltonics).
Endothelial cell E-selectin expression assay
Primary human umbilical endothelial cells (passaged 3-5 times) (Clonetics, San Diego, USA) were plated in a 96-well plate format. Endothelial cells were stimulated (in triplicate) for 4 hours at 37ºC with either isolated LPS or intact cells (as indicated in the figure legend), that had been mixed by vortexing in cell stimulation medium containing 5% human serum. Endothelial cell E-selectin expression was detected by a previously described ELISA protocol (Reife et al., 2006) and data were plotted using GraphPad Prism software. Data sets were normalized to the unstimulated control and expressed as fold E-selectin expression. Asterisks illustrated above the relevant data points in Figure  4 indicate statistically significant P-values (<0.01) that were obtained by unpaired t-test analyses.
Results
Random genomic mutagenesis of P. gingivalis with the TN4400' transposon identifies the gene, PGN_0524, as a major determinant for PMB resistance
We performed a Tn4400'-based mutagenesis in P. gingivalis (ATCC 33277) according to an established procedure to obtain approximately 2,700 independent colonies containing random genomic insertions of the Tn4400' transposon (Chen et al., 2000; Tang et al., 2000) . The colonies were screened by replica plating on media plates with or without PMB (50 µg⋅mL -1 ). Only one colony (initially designated clone 8-1) was isolated that was unable to grow when plated on TYHK-agar plates containing PMB (50 µg⋅mL -1 ). Our studies have shown that P. gingivalis bearing a genetically engineered deletion of the entire coding sequence of the gene, PGN_0524, designated 0524KO (previously denoted 1587KO based upon P. gingivalis, strain W83) (Coats et al., 2009 ) renders this strain highly sensitive to PMB-mediated killing. Therefore, we examined the coding region of the PGN_0524 gene in clone 8-1 to determine if the Tn4400' transposon had inserted into this locus. PCR analyses demonstrated that the coding region for PGN_0524 was indeed modified relative to the genomic sequence present in the wild-type bacterium (data not shown). To determine the orientation of the transposon insertion in the gene, we sequenced the genomic region of this clone using primers derived from the Tn4400 transposable element (Chen et al., 2000) in combination with primers derived from either the 5'-or 3'-flanking regions of the PGN_0524 locus (Figure 1) . The results of these analyses demonstrated that the Tn4400' transposon is inserted at nucleotide position 404 of the 717 base-pair coding sequence, which encodes phenylalanine 133 (F133) of the 238 amino acid protein sequence. These data indicate that transposon-mediated disruption of the gene, PGN_0524, in clone 8-1 at amino acid F133 of the protein, produces a strain of P. gingivalis (denoted 0524-Tn4400' for the remainder of this study) that exhibits increased sensitivity to PMB (50 µg⋅mL -1 ). These experiments also clearly demonstrate that Tn4400'-based mutagenesis in combination with a rational phenotypic screen is a powerful method to isolate novel genetic determinants of virulence in P. gingivalis.
P. gingivalis strains 0524KO and 0524-Tn4400' display similar dosage sensitivities to PMB
The observation that strain 0524-Tn4400' (clone 8-1) was sensitive to PMB (50 µg⋅mL -1
) and contained an interruption in PGN_0524 strongly suggests that the insertion of Tn4400' in this locus is the underlying basis for the increased sensitivity of 0524-Tn4400' to PMB-dependent killing. Our previous analyses of the 0524KO strain, which bears a deletion of the entire PGN_0524 coding sequence, revealed that the 0524KO mutant is also sensitive to PMB-dependent killing relative to the wild-type strain (Coats et al., 2009) . To confirm that both 0524-Tn4400' and 0524KO strains display similar sensitivities to PMB, we compared the relative sensitivities of wild-type P. gingivalis, 0524-Tn4400', and 0524KO, to PMB-dependent killing (Figure 2) . The results of these experiments demonstrate that both the 0524-Tn4400' and 0524KO strains display identical sensitivities to killing by PMB over a broad dosage range (0-200 µg⋅mL -1 ) that fails to kill wild-type P. gingivalis. insertion in PGN_0524 (0524-Tn4400') or a genomic deletion of PGN_0524 (0524KO) display similarly increased dosage-dependent sensitivities to PMB as compared to wild-type P. gingivalis P. gingivalis 0524-Tn4400' and 0524KO strains exhibit dramatic reductions in the accumulation of non-phosphorylated, tetra-acylated lipid A species relative to wild-type P. gingivalis
We have previously shown that loss of the lipid A 4'-phosphatase, PGN_0524, in the 0524KO mutant results in a drastic reduction in the accumulation of a non-phosphorylated, tetra-acylated lipid A species (m/z 1368) concomitant with the increased accumulation of a mono-phosphorylated, penta-acylated lipid A species (m/z 1688) (Coats et al., 2009) . In that study, we used MALDI-TOF MS analyses to detect the major lipid A species present in the wild-type strain as compared to the 0524KO strain. Specifically, the use of the positive ion mode MALDI-TOF MS analysis permitted efficient detection of the non-phosphorylated, tetra-acylated lipid A structure (m/z 1368) that accumulates in wild-type bacteria, but is absent from 0524KO bacteria. To compare the diagnostic lipid A structures that were derived from wild-type bacteria, 0524KO bacteria, and 0524-Tn4400' bacteria, we performed a similar positive ion mode MALDI-TOF MS analysis (Figure 3 ). These data demonstrate that wild-type P. gingivalis is enriched for the non-phosphorylated, tetra-acylated lipid A (m/z 1368), whereas the 0524-Tn4400' and 0524KO strains fail to accumulate this lipid A species, but are enriched for the mono-phosphorylated, penta-acylated lipid A (m/z 1688) (compare Figures 3A, 3B, and 3C) . Therefore, the loss of PGN_0524 function, through either gene deletion (0524KO), or transposable element-mediated gene disruption (0524-Tn4400'), yield strikingly similar lipid A profiles. These data strongly support the hypothesis that PGN_0524 is a critical genetic determinant necessary for the production of the non-phosphorylated, tetra-acylated-acylated lipid A structure that predominates in P. gingivalis. These results are also consistent with the idea that it is the loss of lipid A 4'-dephosphorylation, resulting from the disruption of PGN_0524, which renders P. gingivalis susceptible to PMB.
Both 0524-Tn4400' and 0524KO strains activate E-selectin expression in human endothelial cells more potently than wild-type P. gingivalis
Another important characteristic associated with the 0524KO strain of P. gingivalis is that it displays an enhanced ability to stimulate host TLR4 responses in human endothelial cells as compared to wild-type P. gingivalis LPS or whole bacteria (Coats et al., 2009 ). To determine whether or not the 0524-Tn4400' strain displayed similar capabilities, the relative potencies of LPS derived from wild-type P. gingivalis, 0524KO, and 0524-Tn4400', or the respective bacteria to elicit TLR4-depndent E-selectin responses in endothelial cells were compared (Figure 4) . Notably, the LPS derived from both 0524KO and 0524-Tn4400' were significantly more potent activators of E-selectin expression as compared to LPS isolated from wild-type P. gingivalis ( Figure 4A ). Furthermore, preparations of intact 05244KO and 0524-Tn4400' bacteria displayed a dose-dependent activation of E-selectin expression that was significantly more potent than intact wild-type P. Figure 3 The P. gingivalis mutant strains, 0524-Tn4400' and 0524KO, both fail to generate non-phosphorylated, tetra-acylated lipid A structures relative to wild-type P. gingivalis
Positive ion-mode MALDI-TOF MS Lipid A analyses of preparations derived from (A) wild-type, (B) 0524KO, and (C) 0524-Tn4400' strains of P. gingivalis, show that both the 0524KO and the 0524-Tn4400' mutant strains display a pronounced increase in the pentaacylated mono-phosphorylated lipid A (P-1688-), and a marked reduction in the accumulation of the tetra-acylated non-phosphorylated lipid A ion (-1368-) relative to the wild-type strain of P. gingivalis. gingivalis bacteria ( Figure 4B ). These data demonstrate that the disruption of PGN_0524 in P. gingivalis by either gene deletion (0524KO) or transposon insertion (0524-Tn4400') significantly increase the ability of this bacterium to activate TLR4-dependent host innate immune responses in endothelial cells.
Discussion
In this study, we took advantage of a transposonmediated random mutagenesis strategy combined with a simple phenotypic screen (PMB sensitivity) to probe the genome of P. gingivalis for genetic elements responsible for conferring resistance to cationic antimicrobial peptides. Transposon-mediated mutagenesis in P. gingivalis has been successfully used to identify novel genes involved in the regulation of gingipain anchoring and expression as well as fimbriation, suggesting that it is a simple and powerful strategy to identify novel virulence factors in this bacterium (Watanabe-Kato et al., 1998; Simpson et al., 1999; Shoji et al., 2002) . The utility of the Tn4400' transposon system for generating random genomic mutations in P. gingivalis was previously demonstrated (Chen et al., 2000) . In the present study, our identification of a PMB-sensitive mutant derived from a random Tn4400'-generated library gives additional validation for the utility of the Tn4400' system in P. gingivalis for identifying novel virulence factors by a simple phenotypic screen.
The main finding of this study is that the gene encoding the lipid A 4'-phosphatase, PGN_0524, is the genetic element that confers the pronounced resistance exhibited by P. gingivalis towards the cationic antimicrobial peptide, PMB. Multiple genetic strategies used by Gram-negative bacteria to evade the action of PMB have been described including decoration of the lipid A with aminoarabinose or phosphoethanolamine (Gunn et al., 1998; Murray et al., 2007) . The requirement for lipid A 4'-phosphatase activity to evade cationic antimicrobial peptides has also been described in the pathogen, Francisella novicida (Wang et al., 2007) . The molecular basis for the ability of the lipid A 4'-phosphatase, PGN_0524, to establish cationic antimicrobial peptide resistance in P. gingivalis is likely due to removal of the lipid A 4'-phosphate moiety. This modification reduces the negative charge potential of the bacterial outer membrane which is believed to be important for productive interaction with positively charged PMB (Gunn et al., 1998; Wang et al., 2007) . However, the removal of the 4'-phosphate also appears to be required for the 3'-O-deacylation of the pentaacylated lipid A to generate non-phosphorylated tetra-acylated lipid A species (Coats et al., 2009) . It is presently unclear how either lipid A 3'-Odeacylation or lipid A 1-dephosphorylation influences PMB resistance in P. gingivalis. It is interesting to note that lipid A 1-dephosphorylation is important in conferring PMB resistance in the bacterium, Helicobacter pylori (Tran et al., 2006) . The accumulation of lipid A lacking phosphates at both the 1-and 4'-positions in P. gingivalis (Rangarajan et al., 2008; Coats et al., 2009) suggests that lipid A 1-phosphate removal might also play a role in the resistance to PMB. Paradoxically, deletion of the lipid A 1-phosphatase, PGN_1713, which contributes to the production of non-phosphorylated lipid A in P. gingivalis, fails to influence the PMB resistance (Coats et al., 2009 ). Nevertheless, it should be noted that even in the absence of PGN_1713 lipid A 1-phosphatase activity, lipid A 1-dephosphorylation persists suggesting that P. gingivalis encodes an additional lipid A 1-phosphatase activity in its genome. Identification of the lipid A 3'-O-deacylase and additional lipid A 1-phosphatase activities should help to resolve the potential roles of these activities in establishing PMB resistance in P. gingivalis.
The mechanism that we have described for PMB resistance suggests that P. gingivalis uses lipid A 4'-dephosphorylation by PGN_0524 to evade critical aspects of host innate immunity that are mediated by cationic antimicrobial peptides including cathelicidins and β-defensins (Bals, 2000) . The induction of resistance against human β-defensins has been described for P. gingivalis (Shelburne et al., 2005) . In addition, P. gingivalis has been reported to resist killing by the cathelicidin, LL-37, as well as β-defensin 3 which constitute important mechanisms of leukocyte and epithelial cellmediated antimicrobial host (Bals, 2000; Yang et al., 2004; Ji et al., 2007; Reddy et al., 2009) . Interestingly, the ability of P. gingivalis to evade LL-37-dependent killing closely parallels its ability to resist neutrophil phagocytosis (Ji et al., 2007) . Future experiments will be aimed at determining the role of PGN_0524 in evading endogenous host cationic antimicrobial peptide activity. These types of experiments should contribute to elucidating the in vivo role that this phosphatase performs in determining the bacterium's ability to escape host innate immune killing defenses.
Finally, a major implication of the lipid A 4'-phosphatase activity controlling the production of non-phosphorylated lipid A extends beyond the context of P. gingivalis to other important Gramnegative pathogens that exhibit phenotypic properties consistent with innate immune evasion. Given the utility of positive ion mode MALDI-TOF MS analysis to efficiently detect non-phosphorylated lipid A in the present study and our recent report (Coats et al., 2009) , re-examination of lipid A isolates from other pathogens using this analytical approach should reveal the prevalence of nonphosphorylated lipid A as a potential mechanism to evade and subvert host defenses.
Conclusion
We used Tn4400'-mediated mutagenesis of the P. gingivalis genome to demonstrate that the gene, PGN_0524, which encodes lipid A 4'-phosphatase activity, is responsible for the ability of P. gingivalis, to resist high doses of PMB and to evade endothelial cell TLR4 responses. These data strongly suggest that PGN_0524 is the key viru-lence factor that determines the ability of the oral pathogen, P. gingivalis, to evade host innate immune defenses involving cationic antimicrobial peptide killing and TLR4 sensing.
